Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Metadoxine is beneficial in alcoholic patients, even with continued alcohol consumption

March 26, 1998

Effects of EAA receptor antagonists on morphine tolerance and dependence

March 9, 1998

HBED proposed as alternative to deferoxamine as iron chelator

March 2, 1998

Nicotine inhaler launched in U.S.

March 2, 1998

The role of dopamine D2 receptor in alcohol intake suppression

Feb. 17, 1998

Orally active iron chelators in development at Novartis

Feb. 16, 1998

TheraTech and SmithKline Beecham join forces on nicotine product

Feb. 3, 1998

Dual 5-HT reuptake inhibitors/5-HT1A antagonists developed at Lilly

Jan. 26, 1998

New chelating agent developed by Israeli researchers

Jan. 21, 1998

U.K. launch for inhaled nicotine replacement therapy

Dec. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...